Express Pharma
Home  »  Latest Updates  »  Ayurvedic products to witness threefold increase in market size

Ayurvedic products to witness threefold increase in market size

10

Ministry of AYUSH and Indian Council of Medicinal Research have decided to have molecular-based studies

A threefold increase in market size of Ayurvedic products from $2.5 billion to $8 billion is envisioned by 2022. This information was stated by Shripad Yesso Naik, Minister of State (Independent Charge) Ministry of AYUSH at the Ayurveda Conclave organised by the Ministry of AYUSH and Confederation of Indian Industry (CII) held in New Delhi.

“Ayurveda is witnessing a resurgence in India and around the globe. It advocates preventive healthcare methods of treatment; it is not a system of medicine, but a science of life and longevity,” added the Minister.

“The government has already begun work on building AIIMS like facilities for Ayurveda across India. To converge the research approach of AYUSH systems with the modern system of medicine, the Ministry of AYUSH and Indian Council of Medicinal Research have decided to have molecular-based studies on specific leads from the Ministry,” observed Naik.

Dr Rajesh Kotecha, Secretary, Ministry of AYUSH, said, “We have to look at research integration and teaching.” Entrepreneurs must leverage the huge demand for Ayurveda, he added, noting that GST has been brought down to five per cent to encourage the sectors.

The healthcare market in India is estimated to grow at a compound annual growth rate of 23 per cent from 2015 to 2020, and is expected to be a $280 billion market by 2020. Shobana Kamineni, President, CII and Vice Chairperson, Apollo Hospital Enterprise, noted that only 10 per cent of the Indian population goes to Ayurvedic centres. “Ayurveda’s rich heritage and recognition as an alternative system of medicine in developed countries provides a good foundation to set an ambitious growth goal defined by increasing by market share, customer access and profitability in both India and global markets,” she said.

Dr Randeep Guleria, Director, AIIMS, commented that intervention is required in terms of upgrading infrastructure, and conducting extensive research and process standardisations to take this ancient system of holistic healing to the masses. Ayurveda has the potential to become an affordable component of a holistic healthcare system and help realise the dream of ‘inclusive healthcare in India’ for all.

Rajiv Vasudevan, Chairman-CII Core Group on Ayurveda and MD, AyurVAID Hospitals, said that CII moots for a concerted effort for commencing core research activities and preservation and availability of raw herbs for manufacturing different formulations. Also, new facilities should be opened up for Ayurveda in non-communicable diseases, geriatrics, and degenerative diseases. He urged the government to make it possible for qualified physicians to practice exclusive Ayurveda and health insurance providers to include Ayurveda in their package.

Comments are closed.